We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Infected Blood Cells' Electrical Properties Indicate Early Malaria

By LabMedica International staff writers
Posted on 27 Aug 2013
A new prototype device recognizes electrical properties of Plasmodium falciparum-infected cells as signatures of disease.

Scientists examined whether it was possible to use electrical impedance as a diagnostic signal for malaria. More...
Several types of infection, including malaria, alter a cell’s impedance, a measure of electrical resistance across the cell membrane. Previous studies had demonstrated electrical changes in later-stage infected cells, but it was not clear that cells that had reached only the ring stage of infection would exhibit electrical changes.

A microfluidic device was constructed that takes a drop of blood and streams it across an electrode that measures a signal differentiating infected cells from uninfected cells. The work, which recognizes ring-stage Plasmodium falciparum infected blood cells, was published August 8, 2003, in the journal Lab On A Chip, could be the first step toward a field-ready, low-cost, portable malaria-detection device.

The microfluidic device built by the scientists was capable of measuring the magnitude and phase of the electrical impedance of individual cells. The device is essentially a cell-counting device, similar in approach to other low-cost, portable devices being developed to diagnose illnesses such as HIV.

“Ultimately the goal would be to create a postage stamp-sized device with integrated electronics that can detect if a person has malaria and at what stage,” said Anantha Chandrakasan, the Joseph F. and Nancy P. Keithley professor of electrical engineering and a principal investigator at Massachusetts Institute of Technology's (MIT; Cambridge, MA, USA) Microsystems Technology Laboratories (MTL) who specializes in developing low-power electronic devices. Similar diagnostics may be applicable to other infections and diseases.

In tests of cells of four cell types—uninfected cells and infected cells at the ring stage, trophozoite, and schizont stages—the device detected small differences in measures of magnitude and seemingly random differences in phase, but not quite enough to definitively differentiate among stages.

However, by mathematically combining the measures into an index called delta, the differences between uninfected cells and all three stages became clear. “It’s much more significant,” said corresponding author Ming Dao, a principal research scientist in the Nanomechanics Laboratory. “It’s a more holistic approach. By using all of the information we can measure, we can detect the differentiating signals much more clearly.”

Malaria is a curable disease, but diagnosis remains a challenge. This ability to discern the circulating parasite’s stage from a drop of blood opens the possibility of building a device that could be used to rapidly diagnose malarial infection in places where laboratories and skilled medical personnel are scarce.

Related Links:

Massachusetts Institute of Technology's
Microsystems Technology Laboratories



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.